This study found that Ki67 expression in liver parenchyma of patients with biliary atresia might be used as a biomarker for predicting native liver survival after KP, and that high Ki67 expression and Ki67+/LCA+ cell numbers at the time of KP were associated with poor clinical prognosis. The gene discussed is MKI67; the disease is biliary atresia.